Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis

PR Newswire
17 Jun 2022, 01:50 GMT+10

HONG KONG, June 17, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, is pleased to announce that Cellenkos, Inc. ("CLNK") recently announced that the U.S. Food and Drug Administration ("FDA") has cleared its Investigational New Drug ("IND") application to initiate a Phase 1b, open-label study of CK0804 as an add on therapy to ruxolitinib in patients with myelofibrosis who experience a suboptimal response to ruxolitinib. Details related to this news can be found via the following Cellenkos news announcement:

Cellenkos Receives FDA Clearance of Investigational New Drug (IND) Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis (prnewswire.com)

Ms. Ting Zheng, Chief Executive Officer and Chairperson of GCBC commented, "The Global Cord Blood team is encouraged by the above news announced by CLNK which highlights a potentially transformative treatment for myelofibrosis patients. We congratulate CLNK team on this development."

About Global Cord Blood Corporation

Global Cord Blood Corporation is an umbilical cord blood banking operator serving multiple regions in China. Global Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. For more information, please visit the Company's website at: http://www.globalcordbloodcorp.com.

For more information, please contact:

Global Cord Blood Corporation

Investor Relations Department

Tel: (+852) 3605-8180

Email: [email protected]

ICR, Inc.

William Zima

Tel: (+86) 10-6583-7511

U.S. Tel: (646) 405-5185

Email: [email protected]

SOURCE Global Cord Blood Corporation

Watch latest videos

News RELEASES

Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Malaysia Sun.

More Information

null in null

Southeast Asia

Section

Trump signals progress on India Trade, criticizes Japan stance

WASHINGTON, D.C.: President Donald Trump says the United States could soon reach a trade deal with India. He believes this deal would...

UN Demands End to Myanmar Violence as Junta’s Election Plans Risk Further Instability

Nearly three months after a devastating earthquake struck Myanmar, the country remains trapped in a deepening crisis, compounded by...

"Big crowd, lot of expectations, he has handled it very well...": Indian bowling coach on Gill's masterclass

Birmingham [UK], July 6 (ANI): Indian bowling coach Morne Morkel hailed skipper Shubman Gill after a record-breaking outing at Birmingham,...

"Thought I could throw better...": Neeraj after winning the inaugural NC Classic

Bengaluru (Karnataka) [India], July 5 (ANI): Following his win at the inaugural NC Classic at Bengaluru, India's world champion and...

"You deserve all of this": Gill earns plaudits from his predecessor Virat Kohli after match-defining exploits in Birmingham

New Delhi [India], July 5 (ANI): India's batting mainstay Virat Kohli had unstinting praise in store for Test captain Shubman Gill,...

Rishabh Pant creates record, first Asian wicketkeeper-batter to score 2,000 runs in SENA countries

Birmingham [UK], July 5 (ANI): Rishabh Pant made history on Saturday, becoming the first Asian wicketkeeper-batter to score 2,000 runs...

Business

Section